Introduction: Employing routine dosimetry protocols for intraoperative electron beam needs further refinements to obtain reliable results. In this regard, the performance of some cylindrical and parallel plate ion chambers for both relative and absolute dosimetry of intraoperative electron beam has been evaluated. Materials and methods: Four different ion chambers including Semiflex and PinPoint cylindrical chambers as well as Advanced Markus and Roos parallel plate ones were employed for PDD measurement and dose rate determination in reference condition of the electron beam produced by LIAC intraoperative accelerator. The results of PDD measurements were compared with those of Gafchromic EBT2 film. Specific recommendations were followed to determine the chamber correction factors including k s and k Q,Q0 for absolute dosimetry in intraoperative reference condition. Results: There was good agreement between PDDs measured by employed chambers and EBT2 film at all nominal energies. Nevertheless, Advanced Markus chamber had the best performance based on the gamma analysis results. Obtained k Q,Q0 and k s for studied ion chambers largely differed from expected values by TRS-398 protocol. The difference of measured dose rates at 12 MeV energy by investigated chambers was less than 1.1% and Advanced Markus had the best accordance with pre-set dose rate by manufacture. Conclusion: Results showed that ignoring the specific recommended procedures in determining the chamber correction factors causes the overestimation of the measured dose. Therefore, dedicated dosimetry protocol should be developed for high dose per pulse intraoperative electron dosimetry including all of the updated correction factors and deviations from routine ionometric electron dosimetry formalisms. According to the recommendations of TRS-398 and TG-51 protocols,
Purpose: This study was designed to assess dosimetric characteristics of 3D-printed personalized multi-channel cylinder applicator (MCCA). Material and methods: UnionTech RS Pro 600 (UnionTech, Inc., Shanghai, China) 3D printer was used for manufacturing MCCA. The geometry of MCCA was designed with Fusion 360 v.2.0.5827 (Autodesk, Inc.) software. The designed file was exported to Meshmixer v.3.5 (Autodesk, Inc.) to create three-dimensional model in stereolithography (STL) file format, which is the common file format for inputting data to 3D printers. We used high-temp resin, FLHTAM02 model (Formlabs Inc., MA, USA), as material in 3D printing process. This resin model has good resistance to high temperature and compatibility with various solvents. We created a simple cubic shape phantom for dosimetric evaluation of the applicator with Gafchromic EBT3 films. Also, Monte Carlo method was applied to simulate MCCA in the same configuration as in experimental test. Results: The mean ± standard deviation (SD) difference between measured and calculated doses in treatment planning system (TPS) for all control points was 0.0860 ±0.0393 Gy, corresponding to 4.01 ±1.21%. The mean ±SD difference between doses calculated by Monte Carlo simulation and TPS for all control points was 0.0996 ±0.0471 Gy, corresponding to 4.58 ±1.05%. The mean ±SD of dose difference between film measurement and Monte Carlo simulation for all control points was 0.0136 ±0.0200 Gy, corresponding to 0.60 ±0.69%. P-value for dose difference between film measurement and TPS, Monte Carlo and TPS, and film measurement and Monte Carlo were 0.7, 0.66, and 0.95, respectively. Conclusions: Dosimetric results and mechanical accuracy of MCCA show that high-temp resin with SLA 3D printing technique can be used for producing patient-specific MCCA in brachytherapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.